A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.
Cheong A, McGrath S, Robinson T, Maliki R, Spurling A, Lock P, Rephaeli A, Nudelman A, Parker BS, Pepe S, Cutts SM.
Cheong A, et al. Among authors: nudelman a.
Biochem Pharmacol. 2021 Mar;185:114410. doi: 10.1016/j.bcp.2021.114410. Epub 2021 Jan 9.
Biochem Pharmacol. 2021.
PMID: 33428897